Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Probiodrug positioning its pGlu-Abeta antibody in the field of Abeta antibodies
May 8, 2018 Off

Probiodrug positioning its pGlu-Abeta antibody in the field of Abeta antibodies

By Dino Mustafić

Euronext listed biopharma company Probiodrug AG, a clinical stage developer therapeutics to treat Alzheimer’s disease (AD), has announced that results…

Novartis’s Alcon cares project 100 commits to reducing cataract blindness globally
May 7, 2018 Off

Novartis’s Alcon cares project 100 commits to reducing cataract blindness globally

By Dino Mustafić

Alcon, a division of Novartis, will give 100 reprocessed Infiniti units to eligible clinics in Asia, Central and South America,…

LEH Pharma appoints Sir Henry Riley as Chairman
May 3, 2018 Off

LEH Pharma appoints Sir Henry Riley as Chairman

By Dino Mustafić

LEH Pharma, the provider of novel ocular implants for macular disorders, has appointed Sir Henry Riley as Chairman of the…

Hikma launches Methotrexate for Inection in USA, which sold for $13 million last year
May 3, 2018 Off

Hikma launches Methotrexate for Inection in USA, which sold for $13 million last year

By Dino Mustafić

Hikma Pharmaceuticals’s US subsidiary West-Ward Pharmaceuticals has launched Methotrexate for Injection, USP in a 1g preservative-free presentation and Methotrexate Injection,…

Concepta in a deal for myLotus delivery in China
April 26, 2018 Off

Concepta in a deal for myLotus delivery in China

By Dino Mustafić

Concepta has signed an agreement with SinoPharm, the largest state-owned pharmaceutical company in China, with annual sales of over £23…

Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home
April 25, 2018 Off

Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home

By Dino Mustafić

Novartis announced the launch of its FocalView app, an ophthalmic digital research platform created with ResearchKit. FocalView aims to allow…

AstraZeneca disappointed in combination of Imfinzi plus tremelimumab
April 24, 2018 Off

AstraZeneca disappointed in combination of Imfinzi plus tremelimumab

By Dino Mustafić

AstraZeneca and MedImmune, its global biologics research and development arm, brought to public high-level results from the Phase III ARCTIC…

April 24, 2018 Off

Sanofi’s leadership change in Research and Development

By Dino Mustafić

Sanofi’s Head of Global Research and Development, Elias Zerhouni, will retire from the company after more than 9 years, in the…

FDA’s Arthritis Advisory Committee recommends approval of Eli Lilly’s, Incyte Corporation’s 2-mg dose of baricitinib
April 24, 2018 Off

FDA’s Arthritis Advisory Committee recommends approval of Eli Lilly’s, Incyte Corporation’s 2-mg dose of baricitinib

By Dino Mustafić

Eli Lilly and Incyte Corporation scored a recommended approval of the 2-mg dose of a once-daily oral medication baricitinib from…

Beximco brings competition to Auxilium’s muscle relaxant Robaxin in USA
April 23, 2018 Off

Beximco brings competition to Auxilium’s muscle relaxant Robaxin in USA

By Dino Mustafić

Beximco Pharmaceuticals has begin the export Methocarbamol tablets to the US, generic equivalent to Auxilium Pharmaceuticals’ muscle relaxant Robaxin tablets, 500mg…

Posts pagination

Previous 1 … 3,391 3,392 3,393 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine